Calcific uraemic arteriolopathy (CUA) is a rare disease and continues to be a clinical challenge. The typical course of CUA is characterized by painful skin discolouration and induration evolving to necrotic ulcerations. Medial calcification of cutaneous arterioles and extensive extracellular matrix remodelling are the hallmarks of CUA. The epidemiology and risk factors associated with this disease are still not fully understood. Moreover, CUA treatment strategies vary significantly among centres and expert recommendations are heterogeneous. Registries may provide important insights and information to increase our knowledge about epidemiology and clinical aspects of CUA and may help to optimize its therapeutic management. In 2006, we established an internet-based registry in Germany (www.calciphylaxie.de) to allow online notification of patients with established or suspected CUA. The registry includes a comprehensive database with questions covering >70 parameters and items regarding patient-related and laboratory data, clinical background and presentation as well as therapeutic strategies. The next phase will be to allow international patient registration via www.calciphylaxis.net as part of the multinational EuCalNet (European Calciphylaxis Network) initiative, which is supported by the ERA-EDTA scientific working group 'CKD-MBD'. Based on the valuable experience with the previous German CUA registry, EuCalNet will be a useful tool to collect data on the rare disease CUA and may become a basis for prospective controlled trials in the near future.

Blueprint for a european calciphylaxis registry initiative. the european calciphylaxis network (eucalnet) / Brandenburg, Vincent; Adragao, Teresa; Dam, Bastiaan Van; Evenepoel, Pieter; Frazão, João M.; Ketteler, Markus; Mazzaferro, Sandro; Torres, Pablo Urena; Ramos, Rosa; Torregrosa, Jose Vicente; Cozzolino, Mario; Massy, Ziad; Covic, Adrian; Vervloet, Marc; Goldsmith, David; Bover, Jordi. - In: CLINICAL KIDNEY JOURNAL. - ISSN 2048-8505. - ELETTRONICO. - 8:5(2015), pp. 567-571. [10.1093/ckj/sfv056]

Blueprint for a european calciphylaxis registry initiative. the european calciphylaxis network (eucalnet)

MAZZAFERRO, SANDRO;
2015

Abstract

Calcific uraemic arteriolopathy (CUA) is a rare disease and continues to be a clinical challenge. The typical course of CUA is characterized by painful skin discolouration and induration evolving to necrotic ulcerations. Medial calcification of cutaneous arterioles and extensive extracellular matrix remodelling are the hallmarks of CUA. The epidemiology and risk factors associated with this disease are still not fully understood. Moreover, CUA treatment strategies vary significantly among centres and expert recommendations are heterogeneous. Registries may provide important insights and information to increase our knowledge about epidemiology and clinical aspects of CUA and may help to optimize its therapeutic management. In 2006, we established an internet-based registry in Germany (www.calciphylaxie.de) to allow online notification of patients with established or suspected CUA. The registry includes a comprehensive database with questions covering >70 parameters and items regarding patient-related and laboratory data, clinical background and presentation as well as therapeutic strategies. The next phase will be to allow international patient registration via www.calciphylaxis.net as part of the multinational EuCalNet (European Calciphylaxis Network) initiative, which is supported by the ERA-EDTA scientific working group 'CKD-MBD'. Based on the valuable experience with the previous German CUA registry, EuCalNet will be a useful tool to collect data on the rare disease CUA and may become a basis for prospective controlled trials in the near future.
2015
calcific uraemic arteriolopathy; calcification; chronic kidney disease; dialysis; vascular disease; nephrology; transplantation
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Blueprint for a european calciphylaxis registry initiative. the european calciphylaxis network (eucalnet) / Brandenburg, Vincent; Adragao, Teresa; Dam, Bastiaan Van; Evenepoel, Pieter; Frazão, João M.; Ketteler, Markus; Mazzaferro, Sandro; Torres, Pablo Urena; Ramos, Rosa; Torregrosa, Jose Vicente; Cozzolino, Mario; Massy, Ziad; Covic, Adrian; Vervloet, Marc; Goldsmith, David; Bover, Jordi. - In: CLINICAL KIDNEY JOURNAL. - ISSN 2048-8505. - ELETTRONICO. - 8:5(2015), pp. 567-571. [10.1093/ckj/sfv056]
File allegati a questo prodotto
File Dimensione Formato  
Brandenburg_Blueprint_2015.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Creative commons
Dimensione 458.15 kB
Formato Adobe PDF
458.15 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/908563
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 13
social impact